Curcumin

Curcumin

SCHEMBL15380838

COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O.O

nearest known ligand 0.97

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO

The experimentally established mechanism targets of Curcumin. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC3 known ✓ O15379 2/20 0.97
▸ HDAC1 known ✓ Q13547 2/20 0.97
▸ HDAC2 known ✓ Q92769 2/20 0.97
▸ HDAC6 known ✓ Q9UBN7 2/20 0.97
▸ ALOX5 known ✓ P09917 2/20 0.97
▸ MEN1 known ✓ O00255 1/20 0.97
▸ EGFR known ✓ P00533 1/20 0.97
▸ THRB known ✓ P10828 1/20 0.97
▸ VDR known ✓ P11473 1/20 0.97
▸ PTGS1 known ✓ P23219 1/20 0.97
▸ PTGS2 known ✓ P35354 1/20 0.97
▸ MMP13 known ✓ P45452 1/20 0.97
▸ GSK3B known ✓ P49841 1/20 0.97
▸ HDAC4 known ✓ P56524 1/20 0.97
▸ HDAC7 known ✓ Q8WUI4 1/20 0.97
▸ HDAC10 known ✓ Q969S8 1/20 0.97
▸ HDAC11 known ✓ Q96DB2 1/20 0.97
▸ HDAC8 known ✓ Q9BY41 1/20 0.97
▸ HDAC9 known ✓ Q9UKV0 1/20 0.97
▸ HDAC5 known ✓ Q9UQL6 1/20 0.97

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Curcumin SCHEMBL15380842 1.00 APP (0.97) APPMAPTBACE1MMP9NFKB1
Curcumin SCHEMBL29636029 1.00 APP (0.97) APPMAPTBACE1MMP9NFKB1
Curcumin SCHEMBL6901740 0.98 APP (1.00) APPMAPTBACE1MMP9NFKB1
Curcumin SCHEMBL2804734 0.98 APP (1.00) APPMAPTBACE1MMP9NFKB1
Curcumin SCHEMBL8440 0.98 APP (1.00) APPMAPTBACE1MMP9NFKB1
Curcumin SCHEMBL17629819 0.98 APP (1.00) APPMAPTBACE1MMP9NFKB1
Curcumin SCHEMBL8336603 0.98 APP (1.00) APPMAPTBACE1MMP9NFKB1
Curcumin SCHEMBL17629818 0.98 APP (1.00) APPMAPTBACE1MMP9NFKB1
Curcumin SCHEMBL250984 0.98 APP (1.00) APPMAPTBACE1MMP9NFKB1
Curcumin SCHEMBL29360171 0.98 APP (1.00) APPMAPTBACE1MMP9NFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2857379-B1 METHOD FOR THE SYNTHESIS OF CURCUMIN ASAC COMPANIA DE BIOTECNOLOGIA E INVESTIG SA (ES) 2020-09-02 — — EP claimed
CN-108289476-A Hydration of animals 雀巢产品技术援助有限公司 2018-07-17 — — CN claimed
EP-2857379-A1 METHOD FOR THE SYNTHESIS OF CURCUMIN Asac Compañía De Biotecnología E Investigación SA (ES) 2015-04-08 — — EP claimed
US-20210369667-A1 COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF RADIATION DERMATITIS, ECZEMA, BURNS, WOUNDS AND CERTAIN CANCERS TPC-API LLC 2021-12-02 — — US disclosed
WO-2020205539-A1 COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF RADIATION DERMATITIS, ECZEMA, BURNS, WOUNDS AND CERTAIN CANCERS VIZURI HEALTH SCIENCES CONSUMER HEALTHCARE, INC. (US) 2020-10-08 — — WO disclosed
EP-2857379-B1 METHOD FOR THE SYNTHESIS OF CURCUMIN ASAC COMPANIA DE BIOTECNOLOGIA E INVESTIG SA (ES) 2020-09-02 — — EP disclosed
EP-2857379-A1 METHOD FOR THE SYNTHESIS OF CURCUMIN Asac Compañía De Biotecnología E Investigación SA (ES) 2015-04-08 — — EP disclosed
EP-2857379-A1 METHOD FOR THE SYNTHESIS OF CURCUMIN Asac Compañía De Biotecnología E Investigación SA (ES) 2015-04-08 — — EP disclosed
WO-2013167770-A1 METHOD FOR THE SYNTHESIS OF CURCUMIN ASAC COMPAÑÍA DE BIOTECNOLOGÍA E INVESTIGACION SA (ES) 2013-11-14 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210369667-A1 COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF RADIATION DERMATITIS, ECZEMA, BURNS, WOUNDS AND CERTAIN CANCERS TP53, TYR, CUTA HDAC3 3301/4885HDAC1 2210/4885HDAC2 2339/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback